Inaugural Global Assisted Reproductive Technology (ART) Industry Excellence Brand and 10-Year Industry Leader List Unveiled

On April 26, 2024, the Inaugural Global ART Industry Excellence Brand and 10-Year Industry Leader Awards Ceremony concluded successfully at the Shanghai Shengjia Art Center. Over 200 distinguished brands and industry elites from more than ten countries gathered to witness the unveiling of the award-winning list.

On April 26, 2024, the Inaugural Global Assisted Reproductive Technology (ART) Industry Excellence Brand and 10-Year Industry Leader Awards Ceremony concluded successfully at the Shanghai Shengjia Art Center. Over 200 distinguished brands and industry elites from more than ten countries gathered to witness the unveiling of the award-winning list.

Over the past decade, the global ART industry has experienced rapid growth driven by multiple factors—including declining human fertility rates, continuous advancements in ART technologies, and broader public adoption. According to preliminary statistics, the number of global ART cycles exceeded 1.5 million in 2023. Against this backdrop, an increasing number of overseas fertility centers, cross-border reproductive medical consulting service providers, fertility-support supplement manufacturers, and genetic testing companies have emerged—alongside many outstanding entrepreneurs.

In recent years, China’s newborn birth numbers have declined sharply for multiple consecutive years, with the national population entering negative growth in 2023. In response, numerous provinces and municipalities across China have introduced policies incorporating ART medical expenses into basic medical insurance coverage, aiming to stimulate population growth. To bridge the information gap between brands and patients—and enable patients to more easily identify high-quality fertility centers, related service providers, and fertility-support products—the World Fertility Industry Alliance (WFA) partnered with Zhuobo Network, China’s leading preconception and reproductive health services platform, to launch the inaugural Global ART Industry Excellence Brand and 10-Year Industry Leader List selection initiative. The voting process was open to end-patients via Zhuobo Network’s official website and mobile app, while industry professionals cast votes across ART-focused online communities nationwide. A total of 92 brands and industry leaders participated; the campaign generated 1.05 million page views and 460,000 total votes. Final winners were selected through a combination of these votes and expert evaluation by the World Fertility Industry Council.

This inaugural list features three major excellence brand categories: 10 Trusted Overseas Fertility Centers, 11 Popular Overseas Reproductive Medical Service Providers, and 8 Favored Fertility-Support Product Brands—as well as 16 recipients of the 10-Year Industry Leader Award. The winners are as follows:

10-Year Industry Leaders in Overseas Reproductive Medicine: Xu-Yang Deng, Wen-Lin Peng, Ji-Fang Niu, Yong-Feng Xiao, Xiao-Qiong Bi, Mei-Lin Shi, Qi Zhang, Juan Xiong, Yuan Wei, Qin Fan, Tao Liang, Kun Hou, Wen-Chao Li, Jia-Fan Lin, Yan-Peng Song, Bin Dong

Trusted Overseas Fertility Centers: HRC Fertility Center, INCINTA Fertility Center (USA), Danruo International Fertility Hospital, CCRH Fertility Center (USA), DHC Fertility Center (Thailand), Ei Hospital (Japan), Molong Tianyun Reproductive Genetics Hospital, UCFC Fertility Center (Colombia), International (Laos) Reproductive Genetics Specialty Hospital, Millennium Fertility Center (Thailand)

Popular Overseas Reproductive Medical Service Providers: Jinxin International, Mengmei Life, Youyunxing, Beijing Youstai, Baolehui, Haiyifu, Shenzhou Zhongtai, Shiguanjia, Aiyouxuan, Shenzhen Yixiao Doctor Group, Jieke Life

Favored Fertility-Support Product Brands: Leyun Dachao, HEALTH & WISDOM, Liangyi, Griffiths, Harvey Pharmaceutical, Shawkea Dandelion Tea, Ciyunzhijia, Yunmeite Nutritionist

The evening featured a roundtable forum titled “The Globalization Pathway for ART Brands,” moderated by Mr. Fang Ji, Deputy Secretary-General of the World Fertility Industry Alliance (WFA). Executives from INCINTA Fertility Center (USA), Danruo Fertility Center (Cambodia), First Renhui Group, and DHC Fertility Center (Thailand) engaged in lively discussion and exchange.

Regarding the ceremony, Mr. Wen-Lin Peng, Executive President of the World Fertility Industry Alliance (WFA), stated: “Due to its highly specialized nature, ART technology is not as straightforward to evaluate as ordinary consumer goods or consumer-level services. Establishing a fair and authoritative ranking system through joint voting by both industry professionals and patients helps guide patient decision-making—and ultimately achieves the goal of ‘good money driving out bad,’ thereby purifying the healthcare environment and safeguarding patient rights.”

Mr. Dongge, Secretary-General of the World Fertility Industry Alliance (WFA), remarked: “The cross-border ART medical sector has grown rapidly over the past decade. We have conducted continuous observation for ten years, surveyed both patients and industry practitioners, and analyzed future development trends. Today’s market is saturated with institutions and products of varying quality—creating information chaos and blind spots for consumers, who often fall victim to misinformation or take inefficient detours. Therefore, we launched this inaugural Excellence Brand and Industry Leader List initiative—to encourage exemplary brands and entrepreneurs to serve as positive role models, guiding the industry toward healthy, sustainable growth.”

On-site interviews were conducted with select award-winning brands and leaders. Mr. Ji-Fang Niu, General Manager of INCINTA Fertility Center (USA), said: “The future of the ART industry looks increasingly promising—we are highly confident that it will help more people fulfill their dreams of parenthood.”

Ms. Li Wang, representing Jinxin International, stated: “As the first international association in this field, WFA’s launch of this inaugural list selection initiative carries profound significance. We hope the Alliance will continue playing an active role in guiding healthy industry development, fostering win-win cooperation, and promoting orderly competition.”

Ms. Mei-Lin Shi, General Manager of Ei Hospital’s China Division, commented: “It is a tremendous honor to receive the Industry Leader title—a recognition of my dedicated service to patients over the years, and also a motivating call to action for the future. We remain steadfastly patient-centered, committed to delivering cutting-edge global medical technologies to patients, bringing them hope and healing.”

On-site interviews were also conducted with reproductive center and overseas medical service provider professionals from multiple countries attending the event. They expressed strong endorsement of the Excellence Brand and Industry Leader List, expressing hopes for increased collaboration with listed organizations—and aspirations to compete for inclusion in future editions.

Prior to the awards ceremony, the World Fertility Industry Alliance (WFA) hosted a Brand Summit, where all winning brands delivered live pitch presentations before over 200 guests from around the globe.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.